Results 51 to 60 of about 15,452,334 (307)
Internalizing Symptoms, Peer Substance Use, and Substance Use Initiation [PDF]
This study used longitudinal survey and social network data covering sixth through ninth grades to test whether internalizing symptoms make early adolescents more prone to (1) exposure to and (2) influence by substance‐using peers. Random effects regressions revealed that increases in symptoms were significantly associated with increases in the ...
Sonja E, Siennick +3 more
openaire +2 more sources
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Substance Use and School and Occupational Performance
Health economists have been actively investigating the relationships between substance use and educational achievement/labor market performance outcomes. Although researchers agree on the direction and magnitude of the relationships between substance use
Popovici, Ioana, French, Michael T
core +1 more source
Photovoice, a participatory photography approach, is an action-oriented research methodology that is increasingly being taken up in research with equity-owed populations and related to sensitive topics.
Trevor Goodyear +8 more
doaj +1 more source
Stimulant safe supply: a potential opportunity to respond to the overdose epidemic
Background Occurring against the backdrop of an overdose crisis, stimulant use and stimulant-involved deaths in North America are increasing at an alarming rate.
Taylor Fleming +4 more
doaj +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Barriers to Substance Use Treatment for Individuals with Substance Use Disorders
Abstract Background Although residential substance use treatment has been shown to improve substance use and other outcomes, most with substance use disorders (SUDs) never seek professional treatment. Much research has been done on the barriers to seeking treatment.
Hudson, Joseph Robert, Manuel, Jennifer
openaire +2 more sources
Background Building capacity for evidence-based treatment and support for people with substance use disorders (SUD) is an urgent priority in the context of the toxic drug poisoning crisis.
Samantha Robinson +5 more
doaj +1 more source
Background JUUL is the fastest growing and highest selling brand of e-cigarette/vapor products in the USA. Assessing the effect of JUUL vapor products on adult smokers’ use of conventional tobacco cigarettes can help inform the potential population ...
Christopher Russell +2 more
doaj +1 more source
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source

